SEC 13F Intelligence

Promethium Advisors,LLC / BMY

Promethium Advisors,LLC’s Bristol-Myers Squibb Co Position

Does Promethium Advisors,LLC own Bristol-Myers Squibb Co (BMY)? Yes — 44.6K shares worth $3M (+1.40% of its 13F portfolio) as of Q1 2026, up from 44.0K shares the prior filed quarter.

Position Value
$3M
Q1 2026
Shares
44.6K
% of Portfolio
+1.40%
Quarters Held
7
currently held

Position History BMY

Reported value by quarter
Q3 ’24: $4MQ3 ’24Q4 ’24: $3MQ4 ’24Q1 ’25: $3MQ1 ’25Q2 ’25: $2MQ2 ’25Q3 ’25: $2MQ3 ’25Q4 ’25: $2MQ4 ’25Q1 ’26: $3MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202644.6K$3M+1.40%
Q4 202544.0K$2M+1.28%
Q3 202544.0K$2M+1.14%
Q2 202544.0K$2M+1.24%
Q1 202546.0K$3M+1.80%
Q4 202456.0K$3M+2.17%
Q3 202469.5K$4M+2.54%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Promethium Advisors,LLC’s full portfolio or all institutional holders of BMY.